- Home
- LNZA vs DXR Comparison
LNZA vs DXR Comparison
Compare LNZA & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNZA | DXR |
|---|---|---|
| Founded | 2005 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 59.0M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | LNZA | DXR |
|---|---|---|
| Price | $6.19 | $11.30 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 50.9K | 9.4K |
| Earning Date | 05-18-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 17.00 | N/A |
| Revenue | ★ $55,845,000.00 | $1,446,345.00 |
| Revenue This Year | $55.80 | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ $0.35 | $33.83 |
| Revenue Growth | ★ 12.61 | N/A |
| 52 Week Low | $5.02 | $8.56 |
| 52 Week High | $44.00 | $14.76 |
Technical Indicators
Market Signals| Indicator | LNZA | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 57.42 |
| Support Level | $5.79 | $9.26 |
| Resistance Level | $6.63 | $10.99 |
| Average True Range (ATR) | 0.35 | 0.56 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 23.83 | 80.47 |
Price Performance
Historical ComparisonAbout LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.